Coronavirus: Benefits of AstraZeneca jab 'outweigh risks'

We start with an update on the Oxford-AstraZeneca vaccine, following an investigation by the the UK medicines regulator into whether it is directly causing rare brain clots. The EU has also been outlining its findings of a review of the jab's safety, saying "unusual blood clots with low blood platelets should be listed as very rare side effects". Our health correspondent brings us more, and today's medical expert, Dr Maria Sundaram, takes us through some of the other coronavirus lines of the day.

Also, we go to Brazil, where there have been more than 4,000 Covid-related deaths in 24 hours for the first time. We speak to our teams on the ground and Brazilians being impacted by the surge in infections.

And doctors in Nigeria have started an indefinite strike, asking for better pay and insurance. We connect to two doctors who tell us what it's been like working during the pandemic.

(Photo: Vial labelled "AstraZeneca coronavirus disease (COVID-19) vaccine" placed on displayed EU flag. Credit: Reuters/Dado Ruvic/Illustration/File Photo)